Search form


Press Releases

Axcan Pharma to Participate in the Gastroenterology Panel at the 2006 RBC Capital Markets Healthcare Conference

Dec 08, 2006 - 03:00 ET

MONT SAINT-HILAIRE, QUEBEC--(CCNMatthews - Dec. 8, 2006) - Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Wednesday, December 13, 2006, President and Chief Executive Officer, Frank Verwiel, M.D., will participate in the gastroenterology panel at the 2006 RBC Capital Markets Healthcare Conference to be held in New York, NY. The gastroenterology panel will take place at 9:00 a.m. (Eastern time).

An audio-only webcast of the panel will also be accessible via the Company's website at and archived for 30 days following the conference.


Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Axcan Pharma Inc.
Isabelle Adjahi
Director, Investor Relations
450-467-2600 ext. 2000